Cathepsin D in host stromal cells, but not in tumor cells, is associated with aggressive behavior in node-negative breast cancer

Human Pathology

Volumn 27, Issue 9, 1996, Pages 890-895

  Nadji, Mehrdad ^a   Fresno, Manuel ^a   Nassiri, Mehdi ^a   Conner, Gregory ^a   Herrero, Agustin ^a   Morales, Azorides R ^a  

^a Department of Pathology ^*

Author keywords

breast cancer; cathepsin D; immunohistochemistry

Indexed keywords

CATHEPSIN D; ESTROGEN RECEPTOR;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER SURVIVAL; FIBROBLAST; HISTIOCYTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; STROMA CELL;

EID: 0029808255     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90214-2     Document Type: Article

References (47)

1. Reid WA, Valler MJ, Kay J: Immunolocalization of cathepsin D in normal and neoplastic human tissues. J Clin Pathol 39:1323-1330, 1986
2. Thorpe SM, Rochefort H, Garcia M, et al: Association between high concentration of Mr 52000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res 49:6008-6014, 1989
3. Spyratos F, Maudelonde T, Brouillet JP, et al: Cathepsin D: An independent prognostic factor for metastasis of breast cancer. Lancet 2:1115-1118, 1989
4. Tandon AK, Clark GM, Chamness GC, et al: Cathepsin D and prognosis in breast cancer. N Engl J Med 322:297-302, 1990
5. Duffy MJ, Brouillet JP, Reilly D, et al: Cathepsin D concentration in breast cancer cytosols: Correlation with biochemical, histological, and clinical findings. Clin Chem 37:101-104, 1991
6. Winstanley JH, Leinster SJ, Cooke TG, et al: Prognostic significance of cathepsin-D in patient with breast cancer. Br J Cancer 67:767-772, 1993
7. Spyratos F, Martin PM, Hacene K, et al: Multiparametric prognostic evaluation of biological factors in primary breast cancer. J Natl Cancer Inst 84:1266-1272, 1992
8. Isola J, Weitz S, Visakorpi T, et al: Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer. J Clin Oncol 11:36-43, 1993
9. Foekens JA, van Putten WL, Portengen H, et al: Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: Multivariate analysis. J Clin Oncol 11:899-908, 1993
10. Domagala W, Striker G, Szadowska A, et al: Cathepsin D in invasive ductal NOS breast carcinoma as defined by immunohisto-chemistry: No correlation with survival at 5 years. Am J Pathol 141:1003-1012, 1992
11. Kute TE, Shao ZM, Sugg NK, et al: Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays. Cancer Res 52:5198-5203, 1992
12. Tetu B, Brisson J, Cote C, et al: Prognostic significance of cathepsin-D expression in node-positive breast carcinoma: An immunohistochemical study. Int J Cancer 55:429-435, 1993
13. Armas OA, Gerald WL, Lesser ML, et al: Immunohistochemical detection of cathepsin D in T2NOMO breast carcinoma. Am J Surg Pathol 18:158-166, 1994
14. Ravdin PM, Tandon AK, Allred DC, et al: Cathepsin D by Western blotting and immunohistochemistry: Failure to confirm correlations with prognosis in node-negative breast cancer. J Clin Oncol 12:467-474, 1994
15. Paradiso A, Mangia A, Correale M, et al: Cytosol cathepsin-D content and proliferative activity of human breast cancer. Breast Cancer Res Treat 23:63-70, 1992
16. Barbi GP, Margallo E, Margiocco M, et al: Evaluation of cathepsin D as prognostic predictor in breast cancer. Oncology 51:329-333, 1994
17. Granata G, Coradini D, Cappelletti V, et al: Prognostic relevance of cathepsin D versus oestrogen receptors in node negative breast cancers. Eur J Cancer 27:970-972, 1991
18. Hahnel R, Harvey J, Robbins P, et al: Cathepsin-D in human breast cancer: Correlation with vascular invasion and other clinical and histopathological characteristics. Anticancer Res 13:2131-2135, 1993
19. Charpin C, Devictor B, Bonnier P, et al: Cathepsin D immunocytochemical assays in breast carcinomas: Image analysis and correlation to prognostic factors. J Pathol 170:463-470, 1993
20. Castiglioni T, Merino MJ, Eisner B, et al: Immunohistochemical analysis of cathepsins D, B and L in human breast cancer. HUM PATHOL 25:857-862, 1994
21. Joensuu H, Toikkanen S, Isola J: Stromal cell cathepsin D expression and long-term survival in breast cancer. Br J Cancer 71:155-159, 1995
22. Veneroni S, Daidone MG, DiFronzo G, et al: Quantitative immunohistochemical determination of cathepsin-D and its relation with other variables. Breast Cancer Res Treat 26:7-13, 1993
23. O'Donoghue AE, Poller DN, Bell JA, et al: Cathepsin D in primary breast carcinoma: Adverse prognosis is associated with expression of cathepsin D in stromal cells. Breast Cancer Res Treat 33:137-145, 1995
24. Elston C, Ellis I: Pathologic prognostic factors in breast cancer. I. The value of histologic grade in breast cancer: Experience form a large study with long term follow-up. Histopathology 19:403-410, 1991
25. Conner GE, Udey JA: Expression and refolding of recombinant human fibroblast procathepsin D. DNA Cell Biol 9:1-9, 1990
26. Rochefort H: Cathepsin D in breast cancer: A tissue marker associated with metastasis. Eur J Cancer 28:1783-1791, 1992
27. Leto G, Pizzolanti G, Tumminello FM, et al: Effects of E-64 (cysteine-proteinase inhibitor) and pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovarian tumors. In Vivo 8:231-236, 1994
28. Briozzo P, Morisset M, Capony F, et al: In vivo degradation of extracellular matrix with Mr 52000 cathepsin D secreted by breast cancer cells. Cancer Res 48:3688-3692, 1988
29. Vetvicka V, Vektvickova J, Fusek M: Effect of human procathepsin D on proliferation of human cell lines. Cancer Lett 79:131-135, 1994
30. Stewart AJ, Piggott NH, May FE, Westley BR: Mitogenic activity of procathepsin D purified from conditioned medium of breast-cancer cells by affinity chromatography on pepstatinyl agarose. Int J Cancer 57:715-718, 1994
31. Leto G, Gebbia N, Rausa L, et al: Cathepsin D in the malignant progression of neoplastic disease. Anticancer Res 12:235-240, 1992
32. Garcia M, Derocq D, Pujol P, et al: Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene 5:1809-1814, 1990
33. Cavalles V, Augereau P, Rochefort H: Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. Proc Natl Acad Sci USA 90:203-207, 1993
34. Augereau P, Miralles F, Cavalles V, et al: Characterization of the proximal estrogen-responsive element of human cathepsin-D gene. Mol Endocrinol 8:693-703, 1994
35. Marsigliante S, Biscozzo L, Greco S, et al: Relation of cathepsin D level to the estrogen receptor in human breast cancer. Int J Clin Lab Res 22:52-57, 1992
36. Touitou I, Vignon F, Cavailles V, et al: Hormonal regulation of cathepsin D following transfection of the estrogen or progesterone receptor into three sex steroid hormone resistant cancer cell lines. J Steroid Biochem Mol Biol 40:231-237, 1991
37. Krishnan V, Wang X, Save S: Estrogen receptor-Sp1 complex mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J Biol Chem 269:15912-15917, 1994
38. Remmele W, Sauer-MantheyJ: Comparative biochemical and immunohistochemical studies on the cathepsin D content of human breast cancer. Virchows Arch [A] Pathol Anat Histopathol 422:467-473, 1993
39. Stonelake PS, Baker PG, Gillespie WM, et al: Steroid receptors, pS2 and cathepsin D in early clinically node-negative breast cancer. Eur J Cancer 30A:5-11, 1994
40. Eng Tan P, Benz CC, Dollbaum C, et al: Prognostic value of cathepsin D expression in breast cancer: Immunohistochemical assessment and correlation with radiometric assay. Ann Oncol 5:329-336, 1994
41. Roger P, Montcourrier P, Maudelonde T, et al: Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: Correlation with cytosolic assay. HUM PATHOL 25:863-871, 1994
42. Johnson MD, Torri JA, Lippman ME, et al: The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res 53:873-877, 1993
43. Himelstein BP, Canete-Soler R, Bernhard EJ, et al: Metallo-proteinases in tumor progression: The contribution of MMP-9. Invasion Metastasis 14:246-258, 1994
44. Wolf C, Lefebvre O, Rouyer N, et al: Stromal proteinases and tumor progression. Med Sci 10:507-515, 1994
45. Basset P, Wolf C, Chambon P: Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: A review. Breast Cancer Res Treat 24:185-193, 1993
46. Iozzo RV, Cohen I: Altered proteoglycan gene expression and the tumor stroma. Experientia 70:199-244, 1993
47. Cardiff RD: Cathepsin D and breast cancer: Useful? HUM PATHOL 25:847-848, 1994 (editorial)